European multi-center evaluation of the Abbott cell-dyn sapphire hematology analyzer

Laboratory Hematology

Volumn 12, Issue 1, 2006, Pages 15-31

  Müller, Robert ^a   Mellors, Ian ^b   Johannessen, Berit ^c   Aarsand, Aasne K ^c   Kiefer, Paul ^a   Hardy, John ^b   Kendall, Richard ^d   Scott, Colin Stephen ^e,f  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b FREEMAN HOSPITAL   (United Kingdom)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d ABBOTT DIAGNOSTICS   (United States)

^e ABBOTT GMBH AND CO KG   (Germany)

^f ABBOTT LABORATORIES   (United Kingdom)

Author keywords

Automated hematology; Cell dyn sapphire; Evaluation

Indexed keywords

ACCURACY; ARTICLE; AUTOANALYZER; BLOOD CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EOSINOPHIL; EUROPE; EVALUATION; HEMATOLOGY; HUMAN; LEUKOCYTE; LYMPHOCYTE; MEDICAL TECHNOLOGY; MONOCYTE; NEUTROPHIL;

EUROPE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RETICULOCYTE COUNT; RETICULOCYTES;

EID: 33645355667     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.05041     Document Type: Article

References (8)

1. England JM, Rowan RM, van Assendelft OW, et al, for the International Committee for Standardization in Haematology. Protocol for evaluation of automated blood cell counters. Clin Lab Haematol. 1984;6:69-84.
2. NCCLS. Reference leukocyte differential count (proportional) and evaluation of instrumental methods. Approved standard H20-A. Wayne, PA; 1991.
3. NCCLS. Evaluation of precision performance of clinical chemistry devices. Approved guideline EP05-A. Wayne, PA; 1995.
4. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem. 1983;21:709-720.
5. FDA. Statistical guidelines on reporting results from studies evaluating diagnostic tests: draft guidelines for industry and FDA reviewer. Rockville, MD; 2003. Available at: http://www.fda.gov/cdrh/osb/guidance/1428.pdf
6. Arroyo JL, Garcia-Marcos MA, Lopez A, et al. Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making process. Transfusion. 2001;41:1212-1216.
7. Kunz D, Kunz WS, Scott CS, Gressner AM. Automated CD61 immunoplatelet analysis of thrombocytopenic samples. Br J Haematol. 2001;112:584-592.
8. Johannessen B, Roemer B, Flatmoen L, Just T, Aarsand AK, Scott CS. Implementation of monoclonal antibody fluorescence on the Abbott Cell-Dyn Sapphire haematology analyser: evaluation of lymphoid, myeloid and platelet markers. Clin Lab Haematol. 2006; in press.